We also performed the Kaplan-Meier analysis in 516 Lower grade glioma patients from TCGA via the R software and revealed that high relative expression of PROX1 is associated with lower survival rates (Figure 1B). This evidence concerns the gene PROX1 and central nervous system cancer.